immunohistochemistry

You have access
High Receptor-interacting Serine/Threonine-protein Kinase 3 (RIP3) Expression Serves as an Independent Poor Prognostic Factor for Triple-negative Breast Carcinoma
YUMIN CHUNG, SINAE KIM, HYUN-SOO KIM and SUNG-IM DO

Anticancer Research May 2022, 42 (5) 2753-2761; DOI: https://doi.org/10.21873/anticanres.15754
You have access
Chloride Intracellular Channel 1 Expression Is Associated With Poor Prognosis of Lung Adenocarcinoma
YUICHIRO YASUDA, TATSUYA NAGANO, NAOE JIMBO, TATSUNORI KIRIU, RATOE SURAYA, DAISUKE HAZAMA, MASATSUGU YAMAMOTO, YOSHIMASA MANIWA, YOSHIHIRO NISHIMURA and KAZUYUKI KOBAYASHI

Anticancer Research January 2022, 42 (1) 271-277; DOI: https://doi.org/10.21873/anticanres.15482
You have access
Clinical Significance of Serglycin Expression in Human Breast Cancer Patients
KEIKO HOSOYA, KANAE NOSAKA, TOMOHIKO SAKABE, MAKOTO WAKAHARA, YUKI OSHIMA, YOSHIMASA SUZUKI, HIROSHIGE NAKAMURA and YOSHIHISA UMEKITA

Anticancer Research January 2022, 42 (1) 279-285; DOI: https://doi.org/10.21873/anticanres.15483
You have access
Prognostic Value of Copine 1 in Patients With Renal Cell Carcinoma
IMAN M. TALAAT, EMAN ABU-GHARBIEH, AMAL HUSSEIN, MAHMOOD HACHIM, ISRAA SOBHY, MOHAMED ELADL and WASEEM EL-HUNEIDI

Anticancer Research January 2022, 42 (1) 355-362; DOI: https://doi.org/10.21873/anticanres.15493
You have access
SHH Expression Is Significantly Associated With Cancer Stem Cell Markers in Oral Squamous Cell Carcinoma
PIOTR CIERPIKOWSKI, ANNA LIS-NAWARA and JULIA BAR

Anticancer Research November 2021, 41 (11) 5405-5413; DOI: https://doi.org/10.21873/anticanres.15352
You have access
Ovarian Serous Carcinoma With a Novel HSP90AB1 Mutation in a Patient With Synchronous Primary Fallopian Tube Serous Carcinoma
JINPING LAI, CAILI TONG and JEREMY R. CHIEN

Anticancer Research September 2021, 41 (9) 4417-4422; DOI: https://doi.org/10.21873/anticanres.15248
You have access
Cytoplasmic-only Expression of Maspin Predicts Poor Prognosis in Patients With Oral Squamous Cell Carcinoma
MAKOTO KAWASAKI, TOMOHIKO SAKABE, ISAMU KODANI and YOSHIHISA UMEKITA

Anticancer Research September 2021, 41 (9) 4563-4570; DOI: https://doi.org/10.21873/anticanres.15269
You have access
PD-L1 Expression and Clinicopathological Factors in Renal Cell Carcinoma: A Comparison of Antibody Clone 73-10 With Clone 28-8
JUNICHI IKEDA, CHISATO OHE, TAKASHI YOSHIDA, HARUYUKI OHSUGI, MOTOHIKO SUGI, KOJI TSUTA and HIDEFUMI KINOSHITA

Anticancer Research September 2021, 41 (9) 4577-4586; DOI: https://doi.org/10.21873/anticanres.15271
You have access
Ceruloplasmin Levels in Cancer Tissues and Urine Are Significant Biomarkers of Pathological Features and Outcome in Bladder Cancer
YUTA MUKAE, HIDENORI ITO, YASUYOSHI MIYATA, KYOHEI ARAKI, TSUYOSHI MATSUDA, NOZOMI AIBARA, YUICHIRO NAKAMURA, TOMOHIRO MATSUO, HIDEKI SAKAI and KANAME OHYAMA

Anticancer Research August 2021, 41 (8) 3815-3823; DOI: https://doi.org/10.21873/anticanres.15174
You have access
The Intestinal Stem Cell Marker SMOC2 Is an Independent Prognostic Marker Associated With Better Survival in Gastric Cancer
CHANG LIM HYUN, SUNG JOON PARK, HYE SUNG KIM, HYUN JOO SONG, HEUNG UP KIM, CHEOL LEE, DONG HUI LEE, YOUNG HEE MAENG, YOUNG SIL KIM and BOGUN JANG

Anticancer Research July 2021, 41 (7) 3689-3698; DOI: https://doi.org/10.21873/anticanres.15160

Main menu

User menu

Search

immunohistochemistry

Pages